SCHOTT to triple ready-to-use vial production capacity in the U.S.

Meeting increasing demand for storing injectable drugs

SCHOTT’s ready-to-use vials are suitable for a range of drugs, e.g. biologics, vaccines, and mRNA-based drugs - Image: SCHOTT/Oana Szekely

As a globally trusted partner for advanced drug containment and delivery solutions, SCHOTT is announcing plans to triple its vial production capacity at its site in Lebanon, PA, USA. In doing so, the international technology company will further strengthen its business for ready-to-use (RTU) solutions, which have emerged as an often preferred drug containment alternative for high-value medications.

“With our investment, we are underlining our commitment to the global pharma industry and particularly the U.S. market. Additionally, we are enhancing our regional manufacturing footprint in Lebanon, Pennsylvania, where we are proudly celebrating our site’s 30th anniversary,” said Andreas Reisse, Executive Vice President of SCHOTT Pharma.